Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
Date first appeared online 10/07/2024
DOI 10.1007/s00125-024-06133-4
Authors Bain S.
Journal Name Diabetologia
Volume 67

Documents
  • 66544.VoR.pdf , Book, © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License.